Genotypes coding for mannose-binding lectin deficiency correlated with cryptococcal meningitis in HIV-uninfected Chinese patients

Journal of Infectious Diseases

Volumn 203, Issue 11, 2011, Pages 1686-1691

  Ou, Xue Ting ^a,b   Wu, Ji Qin ^a,b   Zhu, Li Ping ^a,b   Guan, Ming ^a,b   Xu, Bin ^a,b   Hu, Xiu Ping ^a,b   Wang, Xuan ^a,b   Weng, Xin Hua ^a,b  

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MANNOSE BINDING LECTIN;

ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; CASE CONTROL STUDY; CHINESE; CONTROLLED STUDY; CRYPTOCOCCAL MENINGITIS; DISORDERS OF CARBOHYDRATE METABOLISM; DNA POLYMORPHISM; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC CODE; GENOTYPE; HAPLOTYPE; HOMOZYGOTE; HUMAN; IMMUNOCOMPETENCE; MAJOR CLINICAL STUDY; MALE; MANNOSE BINDING LECTIN DEFICIENCY; MBL2 GENE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; CHINA; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MANNOSE-BINDING LECTIN; MENINGITIS, CRYPTOCOCCAL; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 79956212669     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jir152     Document Type: Article

References (40)

1. Catano G, Agan BK, Kulkarni H, et al. Independent effects of genetic variations in nannose-binding lectin influence the course of HIV disease: the advantage of heterozygosity for coding mutations. J Infect Dis 2008; 198:72-80. (Pubitemid 351920292)
2. Mangano A, Rocco C, Marino SM, et al. Detrimental effects of mannose-binding lectin (MBL2) promoter genotype XA/XA on HIV-1 vertical transmission and AIDS progression. J Infect Dis 2008; 198:694-700.
3. Tan YJ, Liu LF, Luo P, et al. Association between mannose-binding lectin and HIV infection and progression in a Chinese population. Mol Immunol 2009; 47:632-8.
4. Chen J, Xu Z, Ou X, Wang M, Yang X, Li Q. Mannose-binding lectin polymorphisms and recurrent respiratory tract infection in Chinese children. Eur J Pediatr 2009; 168:1305-13.
5. Worthley DL, Johnson DF, Eisen DP, et al. Donor mannose-binding lectin deficiency increases the likelihood of clinically significant infection after liver transplantation. Clin Infect Dis 2009; 48:410-7.
6. Babula O, Lazdane G, Kroica J, Ledger WJ, Witkin SS. Relation between recurrent vulvovaginal candidiasis, vaginal concentrations of mannose-binding lectin, and a mannose-binding lectin gene polymorphism in Latvian women. Clin Infect Dis 2003; 37:733-7. (Pubitemid 37100818)
7. Held K, Thiel S, Loos M, Petry F. Increased susceptibility of complement factor B/C2 double knockout mice and mannan-binding lectin knockout mice to systemic infection with Candida albicans. Mol Immunol 2008; 45:3934-41.
8. Crosdale DJ, Poulton KV, Ollier WE, Thomson W, David W Denning. Mannose-binding lectin gene polymorphisms as a susceptibility factor for chronic necrotizing pulmonary aspergillosis. J Infect Dis 2001; 184:653-6. (Pubitemid 32783560)
9. Lambourne J, Agranoff D, Herbrecht R, et al. Association of mannose-binding lectin deficiency with acute invasive aspergillosis in immunocompromised patients. Clin Infect Dis 2009; 49:1486-91.
10. Eisen DP, Dean MM, O'sullivan MVN, Heatley S, Minchinton RM. Mannose-binding lectin deficiency does not appear to predispose to cryptococcosis in non-immunocompromised patients. Med Mycol 2008; 46:371-5.
11. Granell M, Urbano-Ispizua A, Suarez B, et al. Mannan-binding lectin pathway deficiencies and invasive fungal infections following allogeneic stem cell transplantation. Exp Hematol 2006; 34:1435-41. (Pubitemid 44374841)
12. Bouwman LH, Roep BO, Roos A. Mannose-binding lectin: clinical implications for infection, transplantation and autoimmunity. Hum Immunol 2006; 67:247-56. (Pubitemid 43729357)
13. Smithson A, Munoz A, Suarez B, et al. Association between mannose-binding lectin deficiency and septic shock following acute pyelonephritis due to Escherichia coli. Clin Vaccine Immunol 2007; 14:256-61. (Pubitemid 46570281)
14. Zhang H, Zhou G, Zhi L, et al. Association between mannose-binding lectin genepolymorphisms and susceptibility to severe acute respiratory syndrome coronavirus infection. J Infect Dis 2005; 192:1355-61. (Pubitemid 41401148)
15. Lin CL, Siu LK, Lin JC, et al. Mannose-binding lectin gene polymorphism contributes to recurrence of infective exacerbation in COPD patients http://chestjournal.chestpubs.org/content/early/2010/08/04/chest.10-037Accessed 5 August 2010.
16. Rantala A, Lajunen T, Juvonen R, et al. Mannose-binding lectin concentrations, MBL2 polymorphisms, and susceptibility to respiratory tract infections in young men. J Infect Dis 2008; 198:1247-53.
17. Louropoulou A, van der Velden U, Schoenmaker T, et al. Mannose-binding lectin gene polymorphisms in relation to periodontitis. J Clin Periodontol 2008; 35:923-30.
18. Ruskamp JM, Hoekstra MO, Postma DS, et al. Polymorphisms in the mannan-binding lectin gene are not associated with questionnaire-reported respiratory tract infections in children. J Infect Dis 2008; 198:1707-13.
19. St Swierzko A, Szala A, Cedzynski M, et al. Mannan-binding lectin genotypes and genotype-phenotype relationships in a large cohort of Polish neonates. Hum Immunol 2009; 70:68-72.
20. Mullighan CG, Heatley S, Doherty K, et al. Mannose-binding lectin gene polymorphisms are associated with major infection following allogeneic hemopoietic stem cell transplantation. Blood 2002; 99:3524-9. (Pubitemid 34534518)
21. Madsen HO, Satz ML, Hogh B, Svejgaard A, Garred P. Different molecular events result in low protein levels of mannan-binding lectin in populations from Southeast Africa and South America. J Immunol 1998; 161:3169-75. (Pubitemid 28425746)
22. Bennett JE, Dismukes WE, Duma RJ, et al. A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptococcal meningitis. N Engl J Med 1979; 301:126-31. (Pubitemid 10225854)
23. Dismukes WE, Cloud G, Gallis HA, et al. Treatment of cryptococcal meningitis with combination amphotericin B and flucytosine for four as compared with six weeks. N Engl J Med 1987; 317:334-41. (Pubitemid 17118707)
24. Dromer F, Mathoulin S, Dupont B, Brugiere O, Letenneur L. Comparison of the efficacy of amphothericin B and fluconazole in the treatment of cryptococcosis in human immunodeficiency virus-negative patients: retrospective analysis of 83 cases. Clin Infect Dis 1996; 22:154-60.
25. Pappas PG, Perfect JR, Cloud GA, et al. Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapy. Clin Infect Dis 2001; 33:690-9. (Pubitemid 32762943)
26. Mirza SA, Phelan M, Rimland D, et al. The changing epidemiology of cryptococcosis: an update from population-based active surveillance in 2 large metropolitan areas, 1992-2000. Clin Infect Dis 2003; 36:789-94.
27. Benesová P, Buchta V, Cerman J, Zák P. Cryptococcosis-a review of 13 autopsy cases from a 54-year period in a large hospital. APMIS 2007; 115:177-83.
28. Dromer F, Bernede-Bauduin C, Guillemot D, Lortholary O, French Cryptococcosis Study Group. Major role for amphotericin B-flucytosine combination in severe cryptococcosis. PLoS One 2008; 3:e2870.
29. Lu CH, Chang WN, Chang HW, Chuang YC. The prognostic factors of cryptococcal meningitis in HIV-negative patients. J Hosp Infect 1999; 42:313-20.
30. Shih CC, Chen YC, Chang SC, Luh KT, Hsieh WC. Cryptococcal meningitis in non-HIV-infected patients. Q J Med 2000; 93:245-51.
31. Yao Z, Liao W, Chen R. Management of cryptococcosis in non-HIV-related patients. Med Mycol 2005; 43:245-51. (Pubitemid 40867498)
32. Lui G, Lee N, Ip M, et al. Cryptococcosis in apparently immunocompetent patients. Q J Med 2006; 99:143-51.
33. Zhu LP, Wu QJ, Xu B, Ou XT, Zhang QQ, Weng XH. Cryptococcal meningitis in non-HIV-infected patients in a Chinese teritiary care hospital, 1997-2007. Med Mycol 2010; 48:570-9.
34. Chen J, Varma A, Diaz MR, Litvintseva AP, Wollenberg KK, Kwon-Chung KJ. Cryptococcous neoformans strains and infection in apparently immunocompetent patients, China. Emerg Infect Dis 2008; 14:755-62. (Pubitemid 351838639)
35. Feng X, Yao Z, Ren D, Liao W, Wu J. Genotype and mating type analysis of cryptococcus neoformans and cryptococcus gattii isolates from China that mainly originated from non-HIV-infected patients. FEMS Yeast Res 2008; 8:930-8.
36. Kerrigan AM, Brown GD. C-type lectins and phagocytosis. Immunobiology 2009; 214:562-75.
37. Cross CE, Bancroft GJ. Ingestion of acapsular Cryptococcus neoformans occurs via mannose and beta-glucan receptors, resulting in cytokine production and increased phagocytosis of the encapsulated form. Infect Immun 1995; 63:2604-11.
38. Levitz SM, Tabuni A, Treseler C. Effect of mannose-binding protein on binding of Cryptococcus neoformans to human phagocytes. Infect Immun 1993; 61:4891-3. (Pubitemid 23320551)
39. Chaka W, Verheul AF, Vaihnov VV, et al. Induction of TNF-alpha in human peripheral blood mononuclear cells by mannoprotein of Cryptococcus neoformans involves human mannose binding protein. J Immunol 1997; 159:2979-85. (Pubitemid 127681321)
40. Panepinto JC, Komperda KW, Hacham M, Shin S, Liu X, Williamson PR. Binding of serum mannan binding lectin to a cell integrity-defective Cryptococcus neoformans ccr4Delta mutant. Infect Immun 2007; 75:4769-9.